A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer

BACKGROUND: Since lobaplatin (LBP) has been approved to treat metastatic breast cancer in China, this study aimed to evaluate the safety and efficacy of LBP-based chemotherapy in clinical practice. METHODS: This trial was a prospective, open-label, multicenter phase IV clinical trial that enrolled p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Min, Yuan, Peng, Ouyang, Quchang, Cheng, Ying, Han, Guohui, Wang, Dewei, Ran, Li, Sun, Tao, Zhao, Da, Bai, Yuju, Yang, Shun’e, Wang, Xiaojia, Wu, Rong, Zeng, Xiaohua, Yao, Herui, Ji, Xuening, Jiang, Jun, Hu, Xiaohua, Lin, Haifeng, Zheng, Liping, Zhu, Zhitu, Ge, Wei, Yang, Junlan, Cui, Tongjian, Zhang, Xiaozhi, Lu, Fangyang, Li, Wenhui, Xu, Hongyan, Kang, Mafei, Gong, Ping, Zou, Liqun, Liu, Jiang, Zhang, Hongliang, Yu, Hao, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623367/
https://www.ncbi.nlm.nih.gov/pubmed/36330235
http://dx.doi.org/10.1177/17588359221122715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623367/
https://www.ncbi.nlm.nih.gov/pubmed/36330235
http://dx.doi.org/10.1177/17588359221122715

Ejemplares similares